New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of 69 drug formulations. This includes Sitagliptin and Metformin Hydrochloride Extended-Release Tablets – a combination drug used to treat high blood sugar levels caused by type 2 diabetes, and Olmesartan Medoxomil, Amlodipine & Hydrochlorothiazide Tablet that is used to manage high blood pressure.
The pricing authority has set the retail prices for Sitagliptin and Metformin Hydrochloride Extended-Release Tablets at Rs 13.25. The price of Olmesartan Medoxomil (20 mg), Amlodipine (5 mg) & Hydrochlorothiazide (12.5 mg) Tablet has been fixed at Rs 8.92.
The ceiling price is the amount fixed by the govt for Scheduled Formulations in accordance with the provisions of the Drugs (Prices Control) Order, 2013. It is the maximum price for retailers (excluding GST, if any) for a given product.
In case retail price of any of above formulations is not complied with, as per instant price notification, then concerned manufacturer/marketing company is liable to deposit the overcharged amount along with interest thereon under the provisions of DPCO 2013, read with Essential Commodities Act, 1955,” NPPA stated.
